印度私营部门无需处方基于药房的抗菌药物配药情况:适宜性与成本负担
Pharmacy-based dispensing of antimicrobial agents without prescription in India: appropriateness and cost burden in the private sector.
作者信息
Shet Anita, Sundaresan Suba, Forsberg Birger C
机构信息
Department of Pediatrics, St. John's Medical College Hospital, Bangalore, India ; Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden ; Department of Pediatrics, Division of Infectious Diseases, St. John's Research Institute, Sarjapur Road, Bangalore, 560034 India.
Department of Pediatrics, St. John's Medical College Hospital, Bangalore, India.
出版信息
Antimicrob Resist Infect Control. 2015 Dec 11;4:55. doi: 10.1186/s13756-015-0098-8. eCollection 2015.
BACKGROUND
Inappropriate antibiotic use for treatment of common self-limiting infections is a major problem worldwide. We conducted this study to determine prevalence of non-prescription sale of antimicrobial drugs by pharmacies in Bangalore, India, and to assess their associated avoidable cost within the Indian private healthcare sector.
METHODS
Between 2013 and 2014, two researchers visited 261 pharmacies with simulated clinical scenarios; upper respiratory tract infection in an adult and acute gastroenteritis in a child. Using a pre-defined algorithm, the researchers recorded questions asked by the pharmacist, details of medicines dispensed, and instructions regarding drug allergies, dose and side effects.
RESULTS
Antimicrobial drugs were obtained without prescription from 174 of 261 (66.7 %) pharmacies visited. Instructions regarding dose of these drugs were given by only 58.0 % pharmacies. Only 18.4 % (16/87) of non-antimicrobial-dispensing pharmacies cited the need for a prescription by a medical practitioner. None gave advice on potential side effects or possible drug allergies. In the upper respiratory infection simulation, 82 (71.3 %) of the 115 pharmacies approached dispensed antimicrobials without a prescription. The most common antimicrobial drug prescribed was amoxicillin (51.2 %), followed by azithromycin and ciprofloxacin (12.2 % each). Among 146 pharmacies where acute gastroenteritis was simulated, 92 (63.0 %) dispensed antimicrobials. Common ones were fluoroquinolones (66.3 %), particularly norfloxacin in combination with metronidazole. Standard treatment for diarrhea such as oral rehydration solution and zinc was prescribed by only 18 of 146 (12.3 %) pharmacies. Assuming the average cost of a 5-day course of common antimicrobials in India is $1.93, with 2.5 and 2.1 annual episodes of adult upper respiratory and childhood gastrointestinal infections respectively, and with 30-45 % of the population of 1.3 billion visiting pharmacies, the estimated cost of unnecessary antimicrobial drugs dispensed by pharmacies in India would range from $1.1 to 1.7 billion.
CONCLUSIONS
The study shows that dispensing of antimicrobial drugs without prescription by pharmacies in the private sector in India within an urban setting was unacceptably high, thus placing a high burden on healthcare expenditure. There is an urgent need to institute measures to curb unnecessary antimicrobial usage in India, address market incentives and involve pharmacists as partners for creating awareness among communities.
背景
在全球范围内,将抗生素用于治疗常见的自限性感染是一个主要问题。我们开展这项研究,以确定印度班加罗尔药房非处方销售抗菌药物的情况,并评估印度私立医疗保健部门内与之相关的可避免成本。
方法
在2013年至2014年期间,两名研究人员带着模拟临床场景走访了261家药房;模拟场景为成人上呼吸道感染和儿童急性肠胃炎。研究人员使用预先定义的算法,记录药剂师提出的问题、所配药品的详细信息以及有关药物过敏、剂量和副作用的说明。
结果
在走访的261家药房中,有174家(66.7%)无需处方就提供了抗菌药物。只有58.0%的药房给出了这些药物的剂量说明。在不提供抗菌药物的药房中,只有18.4%(16/87)提到需要医生处方。没有一家药房就潜在副作用或可能的药物过敏给出建议。在上呼吸道感染模拟场景中,115家被走访的药房中有82家(71.3%)无处方就配了抗菌药物。最常开出的抗菌药物是阿莫西林(51.2%),其次是阿奇霉素和环丙沙星(各占12.2%)。在模拟儿童急性肠胃炎的146家药房中,有92家(63.0%)配了抗菌药物。常见的是氟喹诺酮类药物(66.3%),尤其是诺氟沙星与甲硝唑联用。只有146家药房中的18家(12.3%)开出了腹泻的标准治疗药物,如口服补液盐和锌剂。假设印度一个5天疗程的常见抗菌药物平均成本为1.93美元,成人上呼吸道感染和儿童胃肠道感染的年发病次数分别为2.5次和2.1次,且13亿人口中有30%-45%的人会去药房,那么印度药房配出的不必要抗菌药物的估计成本在11亿至17亿美元之间。
结论
该研究表明,印度城市地区私立部门的药房无处方配出抗菌药物的情况高得令人无法接受,从而给医疗保健支出带来了沉重负担。迫切需要采取措施遏制印度不必要的抗菌药物使用,解决市场激励问题,并让药剂师作为合作伙伴参与提高社区的认识。
相似文献
Antimicrob Resist Infect Control. 2015-12-11
Cochrane Database Syst Rev. 2025-1-29
J Infect Dev Ctries. 2015-5-18
Antimicrob Resist Infect Control. 2018-7-31
Res Social Adm Pharm. 2018-7-29
BMC Health Serv Res. 2017-2-13
引用本文的文献
Antimicrob Steward Healthc Epidemiol. 2025-1-27
Indian J Ophthalmol. 2025-1-1
Ann Med Surg (Lond). 2023-11-2
Integr Pharm Res Pract. 2023-11-24
Front Public Health. 2023
本文引用的文献
Indian J Pharmacol. 2014
Lancet Infect Dis. 2014-7-9
Indian Pediatr. 2014-6
J Pharm Policy Pract. 2013-8-12
Lancet Infect Dis. 2013-11-17
Trop Med Int Health. 2013-3-29
BMC Int Health Hum Rights. 2012-9-25
BMC Public Health. 2012-3-21
Trop Med Int Health. 2011-10-18